Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ECMO and cardiopulmonary support].

Xavier M Mueller1, Hendrik T Tevaearai, Judith Horisberger

  • 1Service de chirurgie cardio-vasculaire, CHUV, Lausanne. Xavier.Mueller@chuv.hospvd.ch

Revue Medicale De La Suisse Romande
|May 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of infected endografts after thoracic endovascular aortic repair: a systematic review.

Science progress·2026
Same author

Thoracic Endovascular Aortic Repair For The Management of Aorto-Esophageal Fistulae: A Systematic Review.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2024
Same author

Apical closure device for full-percutaneous transapical structural and valve procedures with large-sized introducer sheaths: The final preclinical study.

Journal of cardiac surgery·2022
Same author

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2021
Same author

Outcome of right ventricular assist device implantation following left ventricular assist device implantation: Systematic review and meta-analysis.

Perfusion·2021
Same author

Nitric Oxide-cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension.

Journal of cardiovascular pharmacology and therapeutics·2021
Same journal

Accelerated sedimentation and hyperproteinemia.

Revue medicale de la Suisse romande·2010
Same journal

Treatment of a hydrothorax.

Revue medicale de la Suisse romande·2010
Same journal

Edema on pilgrim.

Revue medicale de la Suisse romande·2010
Same journal

Lymphosarcoma of the pancreatic compartment.

Revue medicale de la Suisse romande·2010
Same journal

Relief photography.

Revue medicale de la Suisse romande·2010
Same journal

Suture and nerve graft.

Revue medicale de la Suisse romande·2010
See all related articles

Extracorporeal membrane oxygenation (ECMO) offers temporary cardiopulmonary support for severe cardiac and respiratory failure. It bridges patients to definitive treatments like cardiac surgery or heart transplantation, despite limitations like hemorrhage risk.

Area of Science:

  • Cardiology
  • Cardiopulmonary Support
  • Medical Technology

Context:

  • Extracorporeal membrane oxygenation (ECMO) has evolved from respiratory support to a critical intervention for acute cardiac failure.
  • Indications now include cardiogenic shock post-cardiac surgery or myocardial infarction, refractory to conventional therapies.

Purpose:

  • To provide temporary hemodynamic stability for patients with severe cardiopulmonary compromise.
  • To serve as a bridge to invasive cardiac procedures, long-term ventricular assist devices, or heart transplantation.

Summary:

  • ECMO functions as prolonged cardiopulmonary bypass, offering extended cardio-respiratory support.
  • Advantages include less invasive application, simpler implantation, and lower cost compared to long-term ventricular assist devices.

Related Experiment Videos

  • Limitations involve a short support duration (7-10 days) primarily due to hemorrhage risks.

    • Impact:

    • Facilitates critical interventions such as coronary bypass or percutaneous dilatation.
    • Crucial in managing patients awaiting heart transplantation due to organ donor shortages.
    • Enhances patient eligibility assessment for long-term mechanical circulatory support.